Let'S Evolve Life Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 180.27%
- Profit Growth 205.82%
- Ebitda 175.90%
- Net Worth 86.90%
- Total Assets 152.81%
About Let'S Evolve Life
Let's Evolve Life Private Limited (LELPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 May 2021 (Three years and nine months 0 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jeevika Gupta and Mehul Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100MH2021PTC360022
-
Company No.
360022
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 May 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Let'S Evolve Life?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Shah
|
Director | 06-May-2021 | Current |
|
Jeevika Gupta
|
Director | 06-May-2021 | Current |
Financial Performance of Let'S Evolve Life.
Let'S Evolve Life Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 180.27% increase. The company also saw a substantial improvement in profitability, with a 205.82% increase in profit. The company's net worth Soared by an impressive increase of 86.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Let'S Evolve Life?
Unlock access to Let'S Evolve Life's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Healfinity Pharmaceuticals LlpMehul Shah is a mutual person
-
Noemi Cosmeceuticals Private Limited
Mehul Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Let'S Evolve Life?
Let'S Evolve Life has a workforce of 12 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Let'S Evolve Life, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Let'S Evolve Life's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.